Involvement of P2Y11 receptor in silica nanoparticles 30-induced IL-6 production by human keratinocytes

Toxicology. 2014 Aug 1:322:61-8. doi: 10.1016/j.tox.2014.03.010. Epub 2014 May 2.

Abstract

We have previously reported that P2Y11 receptor mediates IFN-γ-induced IL-6 production in human keratinocytes, suggesting the importance of purinergic signaling in skin inflammatory diseases. In this study, the involvement of various P2 receptors in IL-6 production induced by silica nanoparticle 30 (SNP30) was examined in a human keratinocyte cell line, HaCaT. Exposure to SNP30 increased IL-6 production in the cells. Ecto-nucleotidase (apyrase), a non-selective antagonist of P2Y receptors (suramin), and a selective P2Y11 receptor antagonist (NF157) all inhibited IL-6 production. Nucleotides such as ATP and UTP themselves also significantly increased IL-6 production in the cells. It was further confirmed that ATP was released from HaCaT cells exposed to SNP30. These results support the possible role of ATP in SNP30-induced IL-6 production by HaCaT cells. In conclusion, these data demonstrate that P2Y11 receptor also mediates SNP30-induced IL-6 production in human keratinocytes, confirming that the ATP-P2Y11 purinergic signaling is a common pathway of IL-6 production leading to induction of skin inflammatory diseases.

Keywords: ATP; IL-6 production; P2Y11 receptor; SNP30; Skin inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Cell Survival / drug effects
  • Dermatitis / pathology
  • Dose-Response Relationship, Drug
  • Humans
  • Indicators and Reagents
  • Interferon-gamma / metabolism
  • Interleukin-6 / biosynthesis*
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism*
  • Nanoparticles / toxicity*
  • Particle Size
  • Purinergic P2Y Receptor Agonists / pharmacology
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • Real-Time Polymerase Chain Reaction
  • Receptors, Purinergic P2 / drug effects
  • Receptors, Purinergic P2 / genetics
  • Receptors, Purinergic P2 / physiology*
  • Silicon Dioxide / toxicity*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Indicators and Reagents
  • Interleukin-6
  • P2RY11 protein, human
  • Purinergic P2Y Receptor Agonists
  • Purinergic P2Y Receptor Antagonists
  • Receptors, Purinergic P2
  • Tumor Necrosis Factor-alpha
  • Silicon Dioxide
  • Interferon-gamma
  • Adenosine Triphosphate